We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$21.8B
AUM Growth
+$3.36B
(+18%)
Cap. Flow
+$2.78B
Cap. Flow
% of AUM
12.74%
Top 10 Holdings %
Top 10 Hldgs %
12.04%
Holding
3,109
New
1,280
Increased
559
Reduced
519
Closed
699
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$363M |
| 2 |
Tencent Music
TME
|
+$184M |
| 3 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$182M |
| 4 |
Baidu
BIDU
|
+$146M |
| 5 |
Gaotu Techedu
GOTU
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$204M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$189M |
| 3 |
Zoetis
ZTS
|
+$182M |
| 4 |
Guardant Health
GH
|
+$136M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.03% |
| 2 | Consumer Discretionary | 13.15% |
| 3 | Technology | 10.68% |
| 4 | Financials | 9.81% |
| 5 | Communication Services | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Accenture
ACN
$89.9B
| $76.9M | 0.35% |
+278,322
| New | +$71.9M |
|
52
Inspire Medical Systems
INSP
$1.42B
| $76.1M | 0.35% |
367,471
+220,888
| +151% | +$46.9M |
|
53
CALL
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
| $75.3M | 0.35% |
691,400
+476,800
| +222% | +$53.3M |
|
|
BLDP
54
Ballard Power Systems
BLDP
$874M
| $74.5M | 0.34% |
3,059,652
-544,510
| -15% | -$16.3M |
|
55
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.24B
| $71.5M | 0.33% |
656,793
+127,325
| +24% | +$13.8M |
|
56
Visa
V
$677B
| $71.4M | 0.33% |
337,011
+232,960
| +224% | +$49M |
|
57
Southern Copper
SCCO
$141B
| $70.2M | 0.32% |
1,115,107
+454,673
| +69% | +$30.3M |
|
58
PayPal
PYPL
$49.5B
| $69.7M | 0.32% |
286,879
-133,383
| -32% | -$33.7M |
|
59
Elevance Health
ELV
$81.9B
| $68.6M | 0.31% |
191,037
-46,655
| -20% | -$15M |
|
60
Quanterix
QTRX
$173M
| $65.3M | 0.3% |
1,117,093
+39,873
| +4% | +$2.7M |
|
61
Meta Platforms (Facebook)
META
$1.51T
| $65.1M | 0.3% |
221,031
-32,592
| -13% | -$8.78M |
|
|
62
Carnival Corporation Ltd
CCL
$36.1B
| $64.2M | 0.29% |
2,420,017
-8,012,746
| -77% | -$189M |
|
63
Norwegian Cruise Line
NCLH
$8.89B
| $62.9M | 0.29% |
2,279,660
+2,215,770
| +3,468% | +$59M |
|
64
Tesla
TSLA
$1.24T
| $58M | 0.27% |
260,418
+190,239
| +271% | +$47.8M |
|
|
65
Gaotu Techedu
GOTU
$372M
| $57.9M | 0.27% |
+1,708,937
| New | +$139M |
|
66
RH
RH
$3.3B
| $57.7M | 0.26% |
96,657
+85,875
| +796% | +$42.3M |
|
67
Arvinas
ARVN
$518M
| $57.3M | 0.26% |
867,257
+4,150
| +0.5% | +$317K |
|
|
HAPN
68
Happen Inc
HAPN
$2.08B
| $56.6M | 0.26% |
+3,423,845
| New | +$45.1M |
|
69
Agilent Technologies
A
$39.1B
| $56.4M | 0.26% |
443,403
-627,810
| -59% | -$77.6M |
|
|
RP
70
DELISTED
RealPage, Inc.
RP
| $55.9M | 0.26% |
641,037
+517,847
| +420% | +$45M |
|
|
ALXN
71
DELISTED
Alexion Pharmaceuticals
ALXN
| $54.5M | 0.25% |
356,266
+189,797
| +114% | +$29.4M |
|
72
Vail Resorts
MTN
$5.19B
| $54.1M | 0.25% |
185,454
+166,206
| +863% | +$48.4M |
|
73
Carvana
CVNA
$43.3B
| $53.7M | 0.25% |
1,022,770
+458,975
| +81% | +$25.3M |
|
|
74
CALL
Tesla
TSLA
$1.24T
| $52.5M | 0.24% |
+235,800
| New | +$59.2M |
|
75
Telus
TU
$16B
| $52.5M | 0.24% |
2,636,503
+2,482,528
| +1,612% | +$51.6M |
|
Similar funds
Marshall Wace's Q1 2021 Portfolio in Review
As of Q1 2021, Marshall Wace held 3,109 positions worth $21.8B, up 18% from $18.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Marshall Wace deployed $2.78B of net new capital in Q1 2021, opening 1,280 new positions and adding to 559 existing holdings. Its largest new stake was Paramount Global Class B: 5,936,494 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $204M trimmed.
- Marshall Wace's largest Q1 2021 buy was Paramount Global Class B: 5,936,494 shares worth $268M.
- Marshall Wace added most to Farfetch Limited Class A Ordinary Shares in Q1 2021, an estimated $182M increase.
- Marshall Wace's biggest Q1 2021 reduction was Thermo Fisher Scientific, cutting an estimated $204M.
- Marshall Wace fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q1 2021, selling an estimated $76.2M.
- Marshall Wace's ten largest holdings make up 12% of its $21.8B portfolio in Q1 2021.
- Marshall Wace opened 1,280 new positions and closed 699 in Q1 2021.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $21.8B.
Based on Marshall Wace's 13F filing for Q1 2021, filed 17 May 2021.